The goal of an HIV vaccine is to generate robust and durable protective Ab.

Understanding how protective Ab responses develop and how to increase their efficacy are both major knowledge gaps.

Advancement in immunogen selection and vaccine design that will rapidly elicit a protective Ab response is considered critical for HIV vaccine protective efficacy.